{
    "medicine_id": "1c9ccd723af93b360e53c05fb65af3b0a71872ee",
    "platform_id": "DB09305",
    "metadata": {
        "name": "Repatha 140 mg Injection solution",
        "composition": "140 mg Aptazapine",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for the treatment of depression",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NA",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00752",
                        "description": "The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Aptazapine"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "The risk or severity of adverse effects can be increased when Phenelzine is combined with Aptazapine"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "The risk or severity of adverse effects can be increased when Selegiline is combined with Aptazapine"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "The risk or severity of adverse effects can be increased when Moclobemide is combined with Aptazapine"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Aptazapine"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "The risk or severity of adverse effects can be increased when Rasagiline is combined with Aptazapine"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "The risk or severity of adverse effects can be increased when Pargyline is combined with Aptazapine"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "The risk or severity of adverse effects can be increased when Minaprine is combined with Aptazapine"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "The risk or severity of adverse effects can be increased when Iproniazid is combined with Aptazapine"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "The risk or severity of adverse effects can be increased when Nialamide is combined with Aptazapine"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "The risk or severity of adverse effects can be increased when Pirlindole is combined with Aptazapine"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "The risk or severity of adverse effects can be increased when Toloxatone is combined with Aptazapine"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "The risk or severity of adverse effects can be increased when Hydracarbazine is combined with Aptazapine"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "The risk or severity of adverse effects can be increased when Methylene blue is combined with Aptazapine"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "The risk or severity of adverse effects can be increased when Benmoxin is combined with Aptazapine"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "The risk or severity of adverse effects can be increased when Mebanazine is combined with Aptazapine"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "The risk or severity of adverse effects can be increased when Octamoxin is combined with Aptazapine"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "The risk or severity of adverse effects can be increased when Pheniprazine is combined with Aptazapine"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "The risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Aptazapine"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "The risk or severity of adverse effects can be increased when Pivhydrazine is combined with Aptazapine"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "The risk or severity of adverse effects can be increased when Safrazine is combined with Aptazapine"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "The risk or severity of adverse effects can be increased when Caroxazone is combined with Aptazapine"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "The risk or severity of adverse effects can be increased when Furazolidone is combined with Aptazapine"
                    },
                    {
                        "drugbank-id": "DB08550",
                        "description": "The risk or severity of adverse effects can be increased when 7 8 Dichloro 1 2 3 4 tetrahydroisoquinoline is combined with Aptazapine"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "The risk or severity of adverse effects can be increased when Harmaline is combined with Aptazapine"
                    },
                    {
                        "drugbank-id": "DB13876",
                        "description": "The risk or severity of adverse effects can be increased when Brofaromine is combined with Aptazapine"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "The risk or severity of adverse effects can be increased when Procaine is combined with Aptazapine"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "The risk or severity of adverse effects can be increased when Amphetamine is combined with Aptazapine"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "The risk or severity of adverse effects can be increased when Procarbazine is combined with Aptazapine"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "The risk or severity of adverse effects can be increased when Linezolid is combined with Aptazapine"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "The risk or severity of adverse effects can be increased when Safinamide is combined with Aptazapine"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "The risk or severity of adverse effects can be increased when Clorgiline is combined with Aptazapine"
                    },
                    {
                        "drugbank-id": "DB00451",
                        "description": "The risk or severity of adverse effects can be increased when Levothyroxine is combined with Aptazapine"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}